BackHumana Overview
Humana Inc.

Humana Target Price

Where could HUM trade next? Consensus target price: $380.

Get informed when a big investor buys or sells

+ Follow

Share Price

$406.47

Average Target Price

$384.275.5% downside

26 analysts in the last 4 months

High: $513 | Low: $217

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-24Wolfe ResearchJustin Lake$45010.7% upsideOpen
2026-08-04Morgan Stanley$3709% downsideOpen
2026-07-31Barclays$4070.1% upsideOpen
2026-07-30OppenheimerMichael Wiederhorn$4050.4% downsideOpen
2026-07-30Piper Sandler$46313.9% upsideOpen
2026-07-30Robert W. Baird$3904.1% downsideOpen
2026-07-30Guggenheim$47115.9% upsideOpen
2026-07-30Leerink Partners$51326.2% upsideOpen
2026-07-30UBS$4050.4% downsideOpen
2026-07-29Evercore ISI$48018.1% upsideOpen
2026-07-20Jefferies$4100.9% upsideOpen
2026-07-14Truist FinancialDavid MacDonald$4152.1% upsideOpen
2026-07-13Wells FargoStephen Baxter$50223.5% upsideOpen
2026-07-09RBC Capital$4152.1% upsideOpen
2026-07-07Raymond JamesSarah James$30026.2% downsideOpen
2026-07-07Cantor Fitzgerald$30026.2% downsideOpen
2026-06-08Mizuho Securities$3904.1% downsideOpen
2026-06-04Morgan Stanley$24938.7% downsideOpen
2026-06-03Bernstein$4254.6% upsideOpen
2026-06-01Truist FinancialDavid MacDonald$32021.3% downsideOpen
2026-05-26Barclays$34415.4% downsideOpen
2026-05-22UBS$32021.3% downsideOpen
2026-05-20Mizuho Securities$33517.6% downsideOpen
2026-05-20Deutsche Bank$4418.5% upsideOpen
2026-05-15Morgan StanleyErin Wright$21746.6% downsideOpen
2026-05-13Piper Sandler$25437.5% downsideOpen
2026-05-01Raymond James$26036% downsideOpen
2026-04-30Truist FinancialDavid MacDonald$27033.6% downsideOpen
2026-04-30Oppenheimer$26036% downsideOpen
2026-04-30Deutsche Bank$23542.2% downsideOpen
2026-04-30RBC CapitalBen Hendrix$24639.5% downsideOpen
2026-04-30Guggenheim$26933.8% downsideOpen
2026-04-30Barclays$18055.7% downsideOpen
2026-04-30UBS$26235.5% downsideOpen
2026-04-08Mizuho Securities$25836.5% downsideOpen
2026-04-08Evercore ISI$19552% downsideOpen
2026-02-18Wells Fargo$20649.3% downsideOpen
2026-02-17Truist Financial$20050.8% downsideOpen
2026-02-13Deutsche BankGeorge Hill$18055.7% downsideOpen
2026-02-12Oppenheimer$25038.5% downsideOpen
2026-02-12RBC CapitalBen Hendrix$18953.5% downsideOpen
2026-02-12Raymond JamesSarah James$20150.5% downsideOpen
2026-02-12Morgan Stanley$14664.1% downsideOpen
2026-02-12UBS$19552% downsideOpen
2026-02-12Guggenheim$25238% downsideOpen
2026-02-02Morgan Stanley$17457.2% downsideOpen
2026-01-07Wells Fargo$29028.7% downsideOpen
2026-01-06Bernstein$34415.4% downsideOpen
2025-12-18Morgan StanleyErin Wright$26235.5% downsideOpen
2025-12-05JefferiesDavid Windley$31323% downsideOpen

Humana (HUM) FAQ

Humana posts a target price of $380. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $380 for HUM means covering analysts, on average, see the stock 5.5% downside of $406.47 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for HUM's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Humana's other metric pages and overview cover the third.

Judging Humana against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $380 here, then scan peer and history charts to see if the gap is persistent.